advertisement
Wang S 44
Showing records 1 to 25 | Display all abstracts from Wang S126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Qiao X
Communications biology 2025; 8: 291
125683 Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Wang S
Theranostics 2025; 15: 3551-3570
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Liu J
Drug delivery and translational research 2025; 0:
126805 Impact of COVID-19 on acute angle-closure attack: A retrospective study
Zhang S
Medicine 2024; 103: e40782
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Zhang L
Antioxidants (Basel, Switzerland) 2025; 14:
127086 Metabolic dysregulation in glaucoma
Yang X
Clinical and Experimental Optometry 2025; 0: 1-7
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Wang S
Drug delivery and translational research 2025; 0:
126805 Impact of COVID-19 on acute angle-closure attack: A retrospective study
Mei F
Medicine 2024; 103: e40782
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Guan C
Antioxidants (Basel, Switzerland) 2025; 14:
127086 Metabolic dysregulation in glaucoma
Li S
Clinical and Experimental Optometry 2025; 0: 1-7
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Shi J
Communications biology 2025; 8: 291
125683 Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Yang H
Theranostics 2025; 15: 3551-3570
126805 Impact of COVID-19 on acute angle-closure attack: A retrospective study
Shi Y
Medicine 2024; 103: e40782
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Wang S
Antioxidants (Basel, Switzerland) 2025; 14:
127086 Metabolic dysregulation in glaucoma
Guo H
Clinical and Experimental Optometry 2025; 0: 1-7
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Xu H
Communications biology 2025; 8: 291
125683 Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Zheng J
Theranostics 2025; 15: 3551-3570
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Tan G
Drug delivery and translational research 2025; 0:
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Liu K
Communications biology 2025; 8: 291
125683 Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Tong A
Theranostics 2025; 15: 3551-3570
125257 Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery
Tong B
Drug delivery and translational research 2025; 0:
126805 Impact of COVID-19 on acute angle-closure attack: A retrospective study
Yang D
Medicine 2024; 103: e40782
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Pfeiffer N
Antioxidants (Basel, Switzerland) 2025; 14:
127086 Metabolic dysregulation in glaucoma
Wang S
Clinical and Experimental Optometry 2025; 0: 1-7
125683 Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Mu S
Theranostics 2025; 15: 3551-3570
